Tiny implant wipes out bladder cancer in 82% of patients
SMRTR summary
A pretzel-shaped implant called TAR-200 eliminated bladder tumors in 82% of patients with hard-to-treat bladder cancer during a global clinical trial. The device slowly releases chemotherapy drugs over three weeks rather than hours like traditional treatments, allowing deeper cancer penetration. Most patients saw their cancer disappear within three months, with nearly half remaining cancer-free after one year while experiencing minimal side effects.
SMRTR provides this summary for quick context. The original article belongs to Science Daily.
Read the original article